Magnesium and Cardiovascular Disease

Area of Science:

• Cardiology
• Nephrology
• Biochemistry

Background:

• Magnesium is essential for cellular function, acting as a cofactor for enzymes and regulating ion channels.
• In the heart, magnesium influences neuronal excitation, conduction, and contraction, and impacts vascular tone and atherosclerosis.
• Kidney function is critical for magnesium homeostasis, and kidney disorders can disrupt magnesium balance, increasing cardiovascular disease risk.

Purpose of the Study:

• To review the role of magnesium in cardiovascular physiology and disease.
• To examine the association between magnesium levels and cardiovascular conditions.
• To evaluate the evidence for magnesium supplementation in cardiovascular disease prevention and treatment.

Main Methods:

• Review of observational studies linking magnesium levels to cardiovascular disease.
• Analysis of major clinical trials on magnesium supplementation.
• Discussion of magnesium's role in ion transport and vascular cell function.

Main Results:

• Low magnesium levels are associated with increased risk of atherosclerosis, coronary artery disease, arrhythmias, and heart failure.
• Clinical trials on magnesium supplementation show inconsistent benefits and potential risks of overload.
• Current evidence does not support routine magnesium supplementation for cardiovascular health.

Conclusions:

• Magnesium plays a significant role in cardiovascular health, influencing various physiological processes.
• While low magnesium is linked to cardiovascular disease, supplementation benefits are not definitively established.
• Routine magnesium supplementation is not recommended, except in cases of proven or suspected hypomagnesemia causing cardiac arrhythmias.